|
|
|
Volumn 9, Issue 1, 2000, Pages 31-35
|
|
Improving prognosis in hypertension: Exploring the benefits of angiotensin II type 1 receptor blockade
|
|
Author keywords
Angiotensin II receptor blockers; Candesartan cilexetil; Cardiovascular disease; Hypertension; Prognosis; Renin angiotensin system; Target organ disease
|
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
CANDESARTAN;
CANDESARTAN HEXETIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROCHLOROTHIAZIDE;
ANGIOTENSIN 1 RECEPTOR;
ANGIOTENSIN 2 RECEPTOR;
ANGIOTENSIN RECEPTOR;
ANTIHYPERTENSIVE AGENT;
BENZIMIDAZOLE DERIVATIVE;
BIPHENYL DERIVATIVE;
TETRAZOLE DERIVATIVE;
BINDING AFFINITY;
BLOOD PRESSURE REGULATION;
CAUSE OF DEATH;
CONFERENCE PAPER;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
DRUG TOLERABILITY;
HEART FAILURE;
HEART LEFT VENTRICLE HYPERTROPHY;
HUMAN;
HYPERTENSION;
KIDNEY DISEASE;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
PROGNOSIS;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
DRUG ANTAGONISM;
DRUG COMBINATION;
PHYSIOLOGY;
REVIEW;
ANTIHYPERTENSIVE AGENTS;
BENZIMIDAZOLES;
BIPHENYL COMPOUNDS;
DRUG THERAPY, COMBINATION;
HUMANS;
HYDROCHLOROTHIAZIDE;
HYPERTENSION;
PROGNOSIS;
RECEPTOR, ANGIOTENSIN, TYPE 1;
RECEPTOR, ANGIOTENSIN, TYPE 2;
RECEPTORS, ANGIOTENSIN;
RENIN-ANGIOTENSIN SYSTEM;
TETRAZOLES;
|
|
EID: 0034577057
PISSN: 08038023
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (21)
|
